Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.
Journal: British journal of haematology
Published: June 03, 2021
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
Journal: JAMA
Published: April 20, 2021
Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.
Journal: Blood advances
Published: December 20, 2019
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
Journal: The New England journal of medicine
Published: July 19, 2018
A dose-ranging study of ticagrelor in children aged 3-17 years with sickle cell disease: A 2-part phase 2 study.
Journal: American journal of hematology
Published: June 25, 2018
Children with sickle cell anemia with normal transcranial Doppler ultrasounds and without silent infarcts have a low incidence of new strokes.
Journal: American journal of hematology
Published: February 27, 2018
Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non-transfused cohorts.
Journal: American journal of hematology
Published: June 05, 2017
Invasive Pneumococcal Disease in Patients With Sickle Cell Disease.
Journal: Journal of pediatric hematology/oncology
Published: May 25, 2017
Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease Module.
Journal: Health and quality of life outcomes
Published: August 01, 2016
Low molecular weight heparin inhibits sickle erythrocyte adhesion to VCAM-1 through VLA-4 blockade in a standardized microfluidic flow adhesion assay.
Journal: British journal of haematology
Published: June 25, 2016
Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.
Journal: British journal of haematology
Published: May 26, 2016
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
Journal: Lancet (London, England)
Published: December 17, 2015
Last Updated: 09/26/2026